← Open Payments lookup

DAVID HARRIS: Open Payments

NPI 1497799951 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,649 in 123 payments from 18 companies in 2025. Trend: 2023 $1,834 · 2024 $2,779 · 2025 $2,649

Food & beverage: $2,570Education: $80
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.13$355
Otsuka America Pharmaceutical, Inc.16$343
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$290
Neurocrine BioSciences, Inc.14$266
E.R. Squibb & Sons, L.L.C.12$265
Janssen Pharmaceuticals, Inc10$250
Axsome Therapeutics, Inc.5$210
Alkermes, Inc.7$162
Luye Pharma (USA) Ltd.6$102
Collegium Pharmaceutical, Inc.5$100

Products named: CAPLYTA, INGREZZA, COBENFY, INVEGA SUSTENNA, Auvelity, ARISTADA, ABILIFY MAINTENA, AUSTEDO XR.

Industry payments across MI — which companies pay providers there.